 Travis Nemkov
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 43 | 2024 | 566 | 6.360 |
Why?
| | Metabolomics | 31 | 2024 | 530 | 3.740 |
Why?
| | Metabolome | 23 | 2023 | 283 | 2.970 |
Why?
| | Blood Preservation | 23 | 2024 | 231 | 2.790 |
Why?
| | Blood Donors | 8 | 2024 | 84 | 2.200 |
Why?
| | Mass Spectrometry | 11 | 2019 | 652 | 1.450 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 123 | 1.420 |
Why?
| | Erythrocyte Transfusion | 11 | 2023 | 159 | 1.350 |
Why?
| | Glycolysis | 18 | 2023 | 222 | 1.130 |
Why?
| | Hypoxia | 10 | 2023 | 932 | 1.100 |
Why?
| | Amino Acids | 10 | 2023 | 454 | 1.060 |
Why?
| | Energy Metabolism | 10 | 2021 | 714 | 0.990 |
Why?
| | Oxidative Stress | 12 | 2022 | 1089 | 0.980 |
Why?
| | Hemolysis | 4 | 2024 | 143 | 0.980 |
Why?
| | Membrane Lipids | 2 | 2021 | 87 | 0.900 |
Why?
| | Proteomics | 7 | 2022 | 835 | 0.890 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 147 | 0.890 |
Why?
| | Athletic Performance | 1 | 2023 | 43 | 0.850 |
Why?
| | Erythroblasts | 1 | 2022 | 12 | 0.840 |
Why?
| | Drosophila Proteins | 5 | 2024 | 161 | 0.810 |
Why?
| | Lipid Metabolism | 6 | 2021 | 461 | 0.790 |
Why?
| | Purines | 4 | 2022 | 156 | 0.770 |
Why?
| | Animals | 59 | 2024 | 32091 | 0.720 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 67 | 0.720 |
Why?
| | Physical Exertion | 1 | 2021 | 209 | 0.690 |
Why?
| | Leukemia | 2 | 2019 | 207 | 0.690 |
Why?
| | Fatty Acids | 7 | 2024 | 393 | 0.670 |
Why?
| | Prescription Drugs | 1 | 2021 | 112 | 0.670 |
Why?
| | Carbon | 2 | 2017 | 165 | 0.660 |
Why?
| | Drosophila melanogaster | 6 | 2024 | 190 | 0.640 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.640 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 531 | 0.630 |
Why?
| | Cell Death | 1 | 2020 | 321 | 0.630 |
Why?
| | Hypoxanthine | 1 | 2017 | 10 | 0.610 |
Why?
| | Muscle, Skeletal | 8 | 2022 | 1455 | 0.590 |
Why?
| | Mice | 31 | 2023 | 15075 | 0.590 |
Why?
| | Bone Marrow | 1 | 2018 | 247 | 0.580 |
Why?
| | Iron | 1 | 2018 | 232 | 0.570 |
Why?
| | Humans | 88 | 2024 | 115297 | 0.560 |
Why?
| | Altitude Sickness | 5 | 2018 | 152 | 0.540 |
Why?
| | Exercise | 3 | 2023 | 1610 | 0.540 |
Why?
| | Nitrogen | 1 | 2017 | 148 | 0.540 |
Why?
| | Oxidation-Reduction | 10 | 2022 | 887 | 0.540 |
Why?
| | Transfusion Medicine | 1 | 2015 | 8 | 0.530 |
Why?
| | Kynurenine | 5 | 2024 | 78 | 0.520 |
Why?
| | Lipids | 1 | 2019 | 577 | 0.500 |
Why?
| | Hemoglobins | 4 | 2022 | 304 | 0.490 |
Why?
| | Receptor, Adenosine A2B | 3 | 2021 | 32 | 0.480 |
Why?
| | Aging | 7 | 2021 | 1636 | 0.470 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 245 | 0.450 |
Why?
| | Mice, Inbred C57BL | 14 | 2021 | 4770 | 0.430 |
Why?
| | Hemorrhage | 2 | 2022 | 598 | 0.420 |
Why?
| | Taste Buds | 1 | 2015 | 209 | 0.420 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 330 | 0.420 |
Why?
| | Inflammation | 6 | 2021 | 2482 | 0.410 |
Why?
| | Oxygen | 5 | 2020 | 818 | 0.400 |
Why?
| | Healthy Volunteers | 7 | 2021 | 184 | 0.400 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 470 | 0.400 |
Why?
| | Anemia | 2 | 2023 | 144 | 0.380 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 646 | 0.370 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 476 | 0.360 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 171 | 0.360 |
Why?
| | Male | 41 | 2023 | 55796 | 0.360 |
Why?
| | Altitude | 4 | 2023 | 404 | 0.350 |
Why?
| | Flavones | 2 | 2019 | 10 | 0.350 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2251 | 0.340 |
Why?
| | Sphingosine | 3 | 2023 | 32 | 0.340 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 118 | 0.340 |
Why?
| | Blood Banks | 3 | 2019 | 38 | 0.330 |
Why?
| | Lysophospholipids | 3 | 2023 | 65 | 0.330 |
Why?
| | Exercise Tolerance | 2 | 2023 | 225 | 0.330 |
Why?
| | Biomarkers | 8 | 2023 | 3450 | 0.320 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 13 | 0.320 |
Why?
| | Acclimatization | 3 | 2018 | 126 | 0.310 |
Why?
| | Thrombosis | 2 | 2022 | 295 | 0.310 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 367 | 0.300 |
Why?
| | Hematopoietic Stem Cells | 2 | 2023 | 356 | 0.300 |
Why?
| | Proteome | 4 | 2020 | 343 | 0.300 |
Why?
| | Hematopoiesis | 2 | 2018 | 175 | 0.290 |
Why?
| | Wounds and Injuries | 3 | 2020 | 656 | 0.290 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 41 | 0.290 |
Why?
| | Female | 39 | 2023 | 59773 | 0.280 |
Why?
| | Plasma | 3 | 2017 | 183 | 0.280 |
Why?
| | Mammals | 3 | 2023 | 251 | 0.280 |
Why?
| | Tryptophan | 4 | 2021 | 134 | 0.280 |
Why?
| | Adult | 23 | 2023 | 30576 | 0.280 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 48 | 0.280 |
Why?
| | Sciuridae | 2 | 2019 | 142 | 0.280 |
Why?
| | Carnitine | 3 | 2021 | 63 | 0.270 |
Why?
| | Isotope Labeling | 2 | 2017 | 74 | 0.270 |
Why?
| | Insulin Resistance | 3 | 2021 | 1083 | 0.270 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 445 | 0.270 |
Why?
| | Collagen | 2 | 2020 | 414 | 0.270 |
Why?
| | Drosophila | 2 | 2024 | 133 | 0.270 |
Why?
| | Rats | 7 | 2021 | 5033 | 0.270 |
Why?
| | Erythropoiesis | 2 | 2023 | 33 | 0.260 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 150 | 0.260 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 343 | 0.250 |
Why?
| | Coronavirus Infections | 2 | 2020 | 336 | 0.250 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 46 | 0.250 |
Why?
| | Cell Line, Tumor | 10 | 2023 | 2756 | 0.250 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 465 | 0.250 |
Why?
| | Blood Platelets | 2 | 2019 | 325 | 0.250 |
Why?
| | Polyamines | 2 | 2022 | 39 | 0.250 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 157 | 0.250 |
Why?
| | Interleukin-1 | 2 | 2021 | 970 | 0.240 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 92 | 0.240 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.240 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 169 | 0.230 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 20 | 0.230 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 12 | 0.230 |
Why?
| | Blood Group Antigens | 1 | 2023 | 14 | 0.230 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 10 | 0.230 |
Why?
| | Oxygen Consumption | 3 | 2023 | 571 | 0.230 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1032 | 0.230 |
Why?
| | Glutamine | 3 | 2019 | 90 | 0.230 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 26 | 0.230 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 40 | 0.230 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 154 | 0.230 |
Why?
| | Succinates | 1 | 2023 | 18 | 0.220 |
Why?
| | Obesity | 5 | 2021 | 2562 | 0.220 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 63 | 0.220 |
Why?
| | Lactates | 1 | 2023 | 83 | 0.220 |
Why?
| | Furin | 1 | 2022 | 13 | 0.220 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 26 | 0.220 |
Why?
| | Liver | 3 | 2019 | 1716 | 0.210 |
Why?
| | Equidae | 1 | 2022 | 4 | 0.210 |
Why?
| | src-Family Kinases | 1 | 2023 | 88 | 0.210 |
Why?
| | Bicycling | 1 | 2023 | 74 | 0.210 |
Why?
| | Glucose | 3 | 2017 | 902 | 0.210 |
Why?
| | Histiocytosis | 1 | 2022 | 8 | 0.210 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 177 | 0.210 |
Why?
| | Sulfonamides | 3 | 2020 | 446 | 0.210 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 107 | 0.200 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 5 | 0.200 |
Why?
| | Mice, Knockout | 4 | 2023 | 2607 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2022 | 82 | 0.200 |
Why?
| | Protein Domains | 1 | 2022 | 210 | 0.200 |
Why?
| | Cholesterol | 2 | 2022 | 368 | 0.200 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 217 | 0.200 |
Why?
| | Sphingolipids | 2 | 2021 | 59 | 0.190 |
Why?
| | Resistance Training | 1 | 2023 | 123 | 0.190 |
Why?
| | Asparagine | 2 | 2018 | 29 | 0.190 |
Why?
| | Ranitidine | 1 | 2021 | 13 | 0.190 |
Why?
| | Cannabidiol | 1 | 2022 | 59 | 0.190 |
Why?
| | Erythrocyte Count | 1 | 2021 | 19 | 0.190 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 229 | 0.190 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 179 | 0.190 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 55 | 0.190 |
Why?
| | Auditory Pathways | 1 | 2021 | 54 | 0.190 |
Why?
| | Syndecan-1 | 1 | 2020 | 28 | 0.190 |
Why?
| | Virulence Factors | 1 | 2022 | 139 | 0.190 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 169 | 0.190 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 33 | 0.190 |
Why?
| | Cell Plasticity | 1 | 2021 | 24 | 0.190 |
Why?
| | Machine Learning | 2 | 2021 | 318 | 0.190 |
Why?
| | Macrophages | 4 | 2022 | 1273 | 0.190 |
Why?
| | Benzothiazoles | 2 | 2017 | 33 | 0.190 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 92 | 0.180 |
Why?
| | Cannabinoids | 1 | 2022 | 116 | 0.180 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 81 | 0.180 |
Why?
| | Stromal Cells | 1 | 2020 | 99 | 0.180 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 78 | 0.180 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 84 | 0.180 |
Why?
| | Osmotic Pressure | 1 | 2020 | 27 | 0.180 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 81 | 0.180 |
Why?
| | Macrophage Activation | 1 | 2021 | 163 | 0.180 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 343 | 0.180 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 21 | 0.180 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 261 | 0.180 |
Why?
| | Taurine | 1 | 2020 | 42 | 0.180 |
Why?
| | Shock | 1 | 2020 | 74 | 0.170 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 191 | 0.170 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.170 |
Why?
| | Phosphatidylserines | 1 | 2020 | 87 | 0.170 |
Why?
| | Hibernation | 2 | 2019 | 72 | 0.170 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 178 | 0.170 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 22 | 0.170 |
Why?
| | Parabiosis | 1 | 2019 | 12 | 0.170 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 286 | 0.170 |
Why?
| | Circadian Clocks | 1 | 2019 | 45 | 0.170 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.170 |
Why?
| | Homeostasis | 2 | 2022 | 579 | 0.160 |
Why?
| | Mitochondria | 3 | 2019 | 756 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 404 | 0.160 |
Why?
| | Transcriptome | 2 | 2021 | 745 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2020 | 79 | 0.160 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1758 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2020 | 137 | 0.160 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 32 | 0.160 |
Why?
| | Aspartic Acid | 1 | 2018 | 81 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 440 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2018 | 43 | 0.160 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 177 | 0.160 |
Why?
| | Adenosine | 2 | 2017 | 202 | 0.160 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 195 | 0.160 |
Why?
| | Arousal | 1 | 2019 | 152 | 0.160 |
Why?
| | Young Adult | 8 | 2021 | 10413 | 0.160 |
Why?
| | Proteostasis | 1 | 2018 | 20 | 0.160 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.150 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 14 | 0.150 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.150 |
Why?
| | Signal Transduction | 7 | 2022 | 4537 | 0.150 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.150 |
Why?
| | Cryopreservation | 1 | 2018 | 93 | 0.150 |
Why?
| | Time Factors | 9 | 2018 | 6133 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2020 | 229 | 0.150 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 356 | 0.150 |
Why?
| | Diglycerides | 1 | 2018 | 55 | 0.150 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.150 |
Why?
| | Neoplasms | 2 | 2022 | 2110 | 0.150 |
Why?
| | Glutaminase | 1 | 2017 | 9 | 0.150 |
Why?
| | Nicotine | 1 | 2020 | 259 | 0.150 |
Why?
| | Calcium | 2 | 2022 | 1107 | 0.150 |
Why?
| | Resuscitation | 2 | 2018 | 215 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
| | Breast Neoplasms | 2 | 2020 | 1858 | 0.150 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 48 | 0.150 |
Why?
| | Limit of Detection | 1 | 2017 | 54 | 0.150 |
Why?
| | Nitriles | 1 | 2018 | 154 | 0.150 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 12 | 0.150 |
Why?
| | Immune System | 1 | 2018 | 174 | 0.150 |
Why?
| | Body Fluids | 1 | 2017 | 58 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 282 | 0.140 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 145 | 0.140 |
Why?
| | Citric Acid | 1 | 2016 | 29 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.140 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 61 | 0.140 |
Why?
| | Inflammasomes | 1 | 2018 | 116 | 0.140 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2016 | 36 | 0.140 |
Why?
| | Interleukin-6 | 1 | 2020 | 668 | 0.140 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 39 | 0.140 |
Why?
| | Folic Acid | 1 | 2017 | 158 | 0.140 |
Why?
| | Reperfusion Injury | 1 | 2018 | 255 | 0.140 |
Why?
| | Lactic Acid | 4 | 2021 | 272 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 304 | 0.140 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 298 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 486 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 413 | 0.140 |
Why?
| | Brain Death | 1 | 2016 | 28 | 0.140 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 548 | 0.140 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.140 |
Why?
| | Models, Biological | 2 | 2021 | 1642 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 73 | 0.130 |
Why?
| | Bacteria | 1 | 2022 | 741 | 0.130 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 66 | 0.130 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 9 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 137 | 0.130 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 6 | 0.130 |
Why?
| | Antioxidants | 1 | 2019 | 528 | 0.130 |
Why?
| | Middle Aged | 9 | 2021 | 26936 | 0.130 |
Why?
| | Vasodilation | 1 | 2018 | 414 | 0.130 |
Why?
| | Anoikis | 1 | 2015 | 33 | 0.130 |
Why?
| | Pandemics | 2 | 2020 | 1330 | 0.130 |
Why?
| | Biochemistry | 1 | 2015 | 40 | 0.130 |
Why?
| | Fluid Therapy | 1 | 2016 | 118 | 0.130 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.130 |
Why?
| | Acidosis | 1 | 2016 | 83 | 0.130 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 41 | 0.130 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 132 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2021 | 733 | 0.130 |
Why?
| | Platelet Transfusion | 1 | 2015 | 54 | 0.130 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 88 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 259 | 0.130 |
Why?
| | Adipose Tissue | 2 | 2017 | 558 | 0.130 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 194 | 0.130 |
Why?
| | Blood Volume | 1 | 2015 | 54 | 0.130 |
Why?
| | Extinction, Biological | 1 | 2015 | 29 | 0.130 |
Why?
| | Sulfur | 3 | 2022 | 44 | 0.130 |
Why?
| | Citrates | 1 | 2014 | 44 | 0.120 |
Why?
| | Cells, Cultured | 5 | 2021 | 3879 | 0.120 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 40 | 0.120 |
Why?
| | Linear Models | 1 | 2017 | 776 | 0.120 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 146 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 597 | 0.120 |
Why?
| | Health Status | 1 | 2019 | 728 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 220 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 827 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1126 | 0.120 |
Why?
| | Sodium Chloride | 1 | 2014 | 132 | 0.120 |
Why?
| | Methionine | 3 | 2020 | 144 | 0.120 |
Why?
| | Phosphates | 1 | 2014 | 158 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2088 | 0.120 |
Why?
| | Proteolysis | 3 | 2020 | 145 | 0.120 |
Why?
| | Fetal Development | 1 | 2016 | 248 | 0.120 |
Why?
| | Dietary Supplements | 1 | 2017 | 459 | 0.110 |
Why?
| | Prognosis | 1 | 2021 | 3337 | 0.110 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 1890 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 387 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 719 | 0.110 |
Why?
| | Blood Transfusion | 3 | 2022 | 250 | 0.110 |
Why?
| | Peptide Fragments | 1 | 2017 | 679 | 0.110 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 341 | 0.110 |
Why?
| | Adenine | 1 | 2014 | 221 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 620 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 455 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2017 | 591 | 0.110 |
Why?
| | Larva | 3 | 2020 | 195 | 0.110 |
Why?
| | Diet | 1 | 2020 | 1093 | 0.110 |
Why?
| | Aged | 5 | 2023 | 19253 | 0.110 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 442 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2016 | 520 | 0.110 |
Why?
| | Muscles | 2 | 2023 | 328 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 615 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3565 | 0.100 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 538 | 0.100 |
Why?
| | Microbiota | 1 | 2018 | 654 | 0.100 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 716 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2016 | 936 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 788 | 0.090 |
Why?
| | Insulin | 2 | 2021 | 2066 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 559 | 0.090 |
Why?
| | Cell Proliferation | 4 | 2019 | 2197 | 0.090 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 43 | 0.090 |
Why?
| | Cell Line | 3 | 2022 | 2628 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 716 | 0.090 |
Why?
| | Phenotype | 4 | 2020 | 2854 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2811 | 0.090 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 6 | 0.090 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 179 | 0.080 |
Why?
| | Cattle | 2 | 2022 | 940 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2019 | 1973 | 0.080 |
Why?
| | Phosphorylation | 3 | 2018 | 1569 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1359 | 0.080 |
Why?
| | Brain | 2 | 2021 | 2371 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 149 | 0.080 |
Why?
| | Diet, High-Fat | 2 | 2019 | 244 | 0.080 |
Why?
| | Macaca | 2 | 2018 | 50 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2023 | 642 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1142 | 0.070 |
Why?
| | Neurons | 1 | 2015 | 1298 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 194 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 776 | 0.070 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 534 | 0.070 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 55 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 33 | 0.070 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 351 | 0.070 |
Why?
| | Apoptosis | 3 | 2021 | 2363 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2018 | 425 | 0.070 |
Why?
| | Mice, Nude | 2 | 2018 | 641 | 0.070 |
Why?
| | Isotonic Solutions | 2 | 2016 | 32 | 0.070 |
Why?
| | Adolescent | 2 | 2021 | 17767 | 0.070 |
Why?
| | Swine | 2 | 2018 | 706 | 0.070 |
Why?
| | Biopsy | 2 | 2020 | 1053 | 0.070 |
Why?
| | Arginine | 2 | 2016 | 235 | 0.060 |
Why?
| | Cold Temperature | 2 | 2016 | 124 | 0.060 |
Why?
| | Blood Glucose | 3 | 2020 | 1819 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1011 | 0.060 |
Why?
| | Glutathione | 2 | 2016 | 302 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 685 | 0.060 |
Why?
| | RNA Interference | 2 | 2017 | 441 | 0.060 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 3 | 0.060 |
Why?
| | Prospective Studies | 3 | 2021 | 6236 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 822 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 546 | 0.060 |
Why?
| | Mutation | 3 | 2022 | 3371 | 0.060 |
Why?
| | Respiratory Therapy | 1 | 2023 | 20 | 0.060 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 37 | 0.060 |
Why?
| | Pantothenic Acid | 1 | 2023 | 4 | 0.060 |
Why?
| | Dasatinib | 1 | 2023 | 45 | 0.060 |
Why?
| | Heme | 1 | 2023 | 53 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 98 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 125 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 50 | 0.050 |
Why?
| | Horses | 1 | 2022 | 98 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 69 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 191 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 131 | 0.050 |
Why?
| | Cell Movement | 2 | 2017 | 869 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 1837 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2579 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2023 | 510 | 0.050 |
Why?
| | Dogs | 1 | 2022 | 346 | 0.050 |
Why?
| | Quality of Life | 2 | 2023 | 2384 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2022 | 201 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 798 | 0.050 |
Why?
| | Cohort Studies | 2 | 2021 | 4960 | 0.050 |
Why?
| | Oncogenes | 1 | 2021 | 104 | 0.050 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 6 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2021 | 77 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 42 | 0.050 |
Why?
| | Candidiasis | 1 | 2021 | 58 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 105 | 0.050 |
Why?
| | Immunity | 1 | 2021 | 124 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2023 | 297 | 0.050 |
Why?
| | Point Mutation | 1 | 2021 | 219 | 0.050 |
Why?
| | Muscle Strength | 1 | 2023 | 279 | 0.050 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 86 | 0.050 |
Why?
| | Cystine | 1 | 2020 | 14 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2021 | 203 | 0.050 |
Why?
| | Genome | 1 | 2022 | 258 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 627 | 0.050 |
Why?
| | Longevity | 1 | 2021 | 137 | 0.050 |
Why?
| | Cochlea | 1 | 2021 | 89 | 0.050 |
Why?
| | Fat Body | 1 | 2020 | 4 | 0.050 |
Why?
| | Creatine | 1 | 2020 | 52 | 0.050 |
Why?
| | Niacinamide | 1 | 2020 | 65 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 799 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 31 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 45 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 355 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 199 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 29 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 204 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 176 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 129 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1661 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 6 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 65 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 140 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 180 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 27 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 16 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 37 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 155 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 428 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 910 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4423 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 85 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 507 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 60 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 187 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 572 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 11 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 67 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 475 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 296 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 29 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 202 | 0.040 |
Why?
| | Formic Acid Esters | 1 | 2017 | 4 | 0.040 |
Why?
| | Crush Injuries | 1 | 2017 | 9 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2366 | 0.040 |
Why?
| | Biological Transport | 1 | 2018 | 375 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 209 | 0.040 |
Why?
| | Metabolism | 1 | 2017 | 36 | 0.040 |
Why?
| | Swine, Miniature | 1 | 2017 | 70 | 0.040 |
Why?
| | Azacitidine | 1 | 2018 | 127 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 424 | 0.040 |
Why?
| | Pyrroles | 1 | 2018 | 185 | 0.040 |
Why?
| | Cytosol | 1 | 2018 | 205 | 0.040 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 34 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 141 | 0.040 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| | Blood Proteins | 1 | 2019 | 231 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 331 | 0.040 |
Why?
| | Fluorenes | 1 | 2017 | 37 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.040 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| | Anaerobiosis | 1 | 2017 | 48 | 0.040 |
Why?
| | Femoral Fractures | 1 | 2017 | 64 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1301 | 0.040 |
Why?
| | Cystathionine | 1 | 2016 | 24 | 0.040 |
Why?
| | Cell Respiration | 1 | 2017 | 75 | 0.040 |
Why?
| | Periodicity | 1 | 2016 | 57 | 0.040 |
Why?
| | Weaning | 1 | 2016 | 53 | 0.040 |
Why?
| | Nucleotides | 1 | 2017 | 113 | 0.040 |
Why?
| | Erythrocyte Aging | 1 | 2016 | 6 | 0.040 |
Why?
| | Ubiquitination | 1 | 2017 | 86 | 0.040 |
Why?
| | Gene Expression | 1 | 2022 | 1451 | 0.040 |
Why?
| | Proteins | 1 | 2022 | 917 | 0.040 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 5 | 0.040 |
Why?
| | Hydrazines | 1 | 2016 | 28 | 0.040 |
Why?
| | Quality Control | 1 | 2017 | 151 | 0.040 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.040 |
Why?
| | NADP | 1 | 2016 | 41 | 0.040 |
Why?
| | Bacterial Proteins | 1 | 2022 | 745 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 41 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 962 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 40 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 242 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 95 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 220 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 137 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 72 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 38 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 51 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 836 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 479 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 58 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 215 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 71 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 307 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 580 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 210 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 136 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 542 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1080 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 273 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 227 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 267 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 214 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 237 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 174 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 5540 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1388 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1218 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 367 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 276 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 137 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 191 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 176 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 124 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1531 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1045 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 211 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 133 | 0.030 |
Why?
| | Europe | 1 | 2015 | 350 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 245 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 91 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 195 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1440 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 321 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 397 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 594 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 293 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 858 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 469 | 0.030 |
Why?
| | Running | 1 | 2017 | 211 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1032 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 459 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 322 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 269 | 0.030 |
Why?
| | Skull | 1 | 2015 | 121 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 541 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 446 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 1989 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 962 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2598 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1311 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 958 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1241 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 522 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 818 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1218 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 269 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3035 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 396 | 0.030 |
Why?
| | Athletes | 1 | 2016 | 323 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 524 | 0.030 |
Why?
| | Fetus | 1 | 2016 | 701 | 0.030 |
Why?
| | NF-kappa B | 1 | 2015 | 634 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 1921 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 1998 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2773 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6432 | 0.020 |
Why?
| | United States | 1 | 2015 | 12310 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|